These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9416420)

  • 1. TRH mimetics: differentiation of antiamnesic potency from antidepressant effect.
    Mazurov AA; Andronati SA; Korotenko TI; Sokolenko NI; Dyadenko AI; Shapiro YE; Gorbatyuk VYa ; Voronina TA
    Bioorg Med Chem; 1997 Nov; 5(11):2029-40. PubMed ID: 9416420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.
    Yamamoto M; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):262-7. PubMed ID: 3143078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
    Ogasawara T; Ukai Y; Tamura M; Kimura K
    Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential anti-depressive effects of thyrotropin releasing hormone (TRH) and its analogues.
    Ogawa N; Mizuno S; Mori A; Nukina I; Ota Z; Yamamoto M
    Peptides; 1984; 5(4):743-6. PubMed ID: 6436797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restricted analogues provide evidence of a biologically active conformation of thyrotropin-releasing hormone.
    Laakkonen L; Li W; Perlman JH; Guarnieri F; Osman R; Moeller KD; Gershengorn MC
    Mol Pharmacol; 1996 Jun; 49(6):1092-6. PubMed ID: 8649348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Studies on antidepressant effects of several overshort peptides (OSP)].
    Shi LY; Ku BS; Yao HY
    Yao Xue Xue Bao; 1991; 26(7):546-7. PubMed ID: 1805514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro thyrotrophin release with thyrotropin-releasing hormone and an analogue, DN-1417.
    Shiota K; Yoshida K; Noguchi C; Nakayama R
    Acta Endocrinol (Copenh); 1984 May; 106(1):71-8. PubMed ID: 6428117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered ligand dissociation rates in thyrotropin-releasing hormone receptors mutated in glutamine 105 of transmembrane helix III.
    del Camino D; Barros F; Pardo LA; de la Peña P
    Biochemistry; 1997 Mar; 36(11):3308-18. PubMed ID: 9116009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of TRH and its analog DN-1417 on anoxia-induced amnesia in mice].
    Yamazaki N; Shintani M; Saji Y; Nagawa Y
    Yakubutsu Seishin Kodo; 1985 May; 5(1):1-9. PubMed ID: 2996254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a new TRH analogue, YM-14673, on disturbance of passive avoidance learning in senescence-accelerated mice.
    Yamamoto M; Iwai A; Ozawa Y
    Pharmacol Biochem Behav; 1990 Mar; 35(3):727-9. PubMed ID: 2111030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear magnetic resonance studies of thyrotropin-releasing hormone (TRH) and analogues incorporating D-histidine and 4-hydroxy-L-proline.
    Aksnes DW; Athanassopoulos C; Magafa V; Aaberg A; Francis GW; Papaioannou D
    Acta Chem Scand (Cph); 1996 May; 50(5):411-6. PubMed ID: 8634183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and conformational studies by 1H- and 13C-NMR spectroscopy of a novel, sterically constrained analogue of thyrotropin-releasing hormone.
    Mapelli C; Van Halbeek H; Stammer CH
    Biopolymers; 1990 Feb; 29(2):407-22. PubMed ID: 2158826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analogs of thyrotropin-releasing hormone in potentiating the spinal monosynaptic reflex in vitro.
    Deshpande SB; Warnick JE
    Eur J Pharmacol; 1994 Dec; 271(2-3):439-44. PubMed ID: 7705444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyrotropin releasing hormone and its analogues on unconsciousness following head injury in mice.
    Tanaka K; Ogawa N; Chou H; Mori A; Yanaihara N
    Regul Pept; 1992 Mar; 38(2):129-33. PubMed ID: 1574607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin-releasing hormone downregulates pyroglutamyl peptidase II activity in adenohypophyseal cells.
    Vargas MA; Joseph-Bravo P; Charli JL
    Neuroendocrinology; 1994 Sep; 60(3):323-30. PubMed ID: 7969791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroliberin (thyrotropin releasing hormone): antagonism of halothane and hexobarbital narcosis in mice. Comparison with pentetrazol, caffeine, d-amphetamine and adrenaline.
    Kruse H; Siegemund G; Rössner M
    Arzneimittelforschung; 1982; 32(3):211-3. PubMed ID: 6805483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropharmacological evaluation of RX 77368--a stabilised analogue of thyrotropin-releasing hormone (TRH).
    Metcalf G; Dettmar PW; Fortune D; Lynn AG; Tulloch IF
    Regul Pept; 1982 Mar; 3(3-4):193-206. PubMed ID: 6805044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in rat regional brain cyclic nucleotides by thyrotropin-releasing hormone (TRH) and its analog DN-1417.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1983 Oct; 33(5):915-26. PubMed ID: 6139495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.